A microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.

TitleA microRNA miR-34a-regulated bimodal switch targets Notch in colon cancer stem cells.
Publication TypeJournal Article
Year of Publication2013
AuthorsBu P, Chen K-Y, Chen JHuan, Wang L, Walters J, Shin YJun, Goerger JP, Sun J, Witherspoon M, Rakhilin N, Li J, Yang H, Milsom J, Lee S, Zipfel W, Jin MM, Gümüş ZH, Lipkin SM, Shen X
JournalCell Stem Cell
Volume12
Issue5
Pagination602-15
Date Published2013 May 02
ISSN1875-9777
KeywordsAged, Aged, 80 and over, Asymmetric Cell Division, Carcinogenesis, Cell Differentiation, Cell Line, Tumor, Cell Lineage, Cell Proliferation, Colonic Neoplasms, Female, Gene Expression Regulation, Neoplastic, Humans, Male, Membrane Proteins, MicroRNAs, Middle Aged, Neoplasm Staging, Neoplastic Stem Cells, Nerve Tissue Proteins, Protein Transport, Receptors, Notch, Signal Transduction, Xenograft Model Antitumor Assays
Abstract

microRNAs regulate developmental cell-fate decisions, tissue homeostasis, and oncogenesis in distinct ways relative to proteins. Here, we show that the tumor suppressor microRNA miR-34a is a cell-fate determinant in early-stage dividing colon cancer stem cells (CCSCs). In pair-cell assays, miR-34a distributes at high levels in differentiating progeny, whereas low levels of miR-34a demarcate self-renewing CCSCs. Moreover, miR-34a loss of function and gain of function alter the balance between self-renewal versus differentiation both in vitro and in vivo. Mechanistically, miR-34a sequesters Notch1 mRNA to generate a sharp threshold response where a bimodal Notch signal specifies the choice between self-renewal and differentiation. In contrast, the canonical cell-fate determinant Numb regulates Notch levels in a continuously graded manner. Altogether, our findings highlight a unique microRNA-regulated mechanism that converts noisy input into a toggle switch for robust cell-fate decisions in CCSCs.

DOI10.1016/j.stem.2013.03.002
Alternate JournalCell Stem Cell
PubMed ID23642368
PubMed Central IDPMC3646336
Grant ListR21CA162483 / CA / NCI NIH HHS / United States
R01GM95990 / GM / NIGMS NIH HHS / United States
R21 CA162483 / CA / NCI NIH HHS / United States
R01 GM095990 / GM / NIGMS NIH HHS / United States
R21CA153049 / CA / NCI NIH HHS / United States
R21 CA153049 / CA / NCI NIH HHS / United States
Related Institute: 
Molecular Imaging Innovations Institute (MI3)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065